Licensed Practical Nurse in Hartsdale, NY Accepting Medicare
4 Licensed Practical Nurse nurses found. Showing 1 - 4
 Sable Romero, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 300 High Point Dr Apt 308, Hartsdale, NY 10530 Phone: 914-625-4745 |
Shawna Y Thompson, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 8 Shelly Ave, Hartsdale, NY 10530 Phone: 646-523-0376 |
Ms. Shanya Blye-watt, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 141 N Central Ave, Hartsdale, NY 10530 Phone: 914-949-7699 Fax: 914-949-3224 |
Ms. Katiana Garcia, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 141 N Central Ave, Hartsdale, NY 10530 Phone: 914-949-7699 Fax: 914-949-3224 |
News Archive
Isansys Lifecare's patient monitoring platform nominated for prestigious award
Isansys Lifecare, a new generation digital healthcare company from Oxford, has fought off competition from across the country to be nominated for a prestigious national innovation award which will see the company heading to Parliament later this month.
USCCB responds to Feb. 2 post on the White House blog
The U.S. Conference of Catholic Bishops has issued the following response to the February 2 post on the White House blog.
Using iPS technology researchers develop new therapies for Parkinson's disease and ALS
Dresden. Dr. Jared Sterneckert is entering the research area "Neurodegenerative Diseases" of the DFG Research Center and Cluster of Excellence at the TU Dresden as a new junior group leader. Since 2006, he has led a team working at the "Max Planck Institute for Molecular Biomedicine" in Münster to develop models of Parkinson's disease and amyotrophic lateral sclerosis.
Research looks at how environment inside a living cell affects protein structure
The syrupy soup of proteins, ribosomes and membranes inside a living cell is so tightly packed it may increase the structural content of proteins by as much as 25 percent, according to new research from Rice University and the University of Houston (UH).
MiMedx awarded QTDP grant for CollaFix drug delivery device
MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has been awarded a Qualifying Therapeutic Discovery Project grant (QTDP) from the U.S. Government. The grant, in the amount of $244,479, has been made to defer some of the Company's research expenditures related to the development of its novel and patented technology, CollaFix™, as a drug delivery device.
› Verified 6 days ago